RxDoctor Payments Data

Fernando Martinez, MD

Family Medicine · Santa Ana, CANPI 1962591198

Payments from drug & device makers

$10,664in general payments, 2019–2025

Across 75 payments — averaging $142.18 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Boehringer Ingelheim International GmbH$9K
  • Amgen$505
  • Novo Nordisk$184
  • Bayer$121
  • AbbVie$85
  • GSK$77
  • plus $444 from 15 others

What the payments were for

  • Consulting fees$9,25987%
  • Food & beverage$1,40513%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$10,664 in reported general payments places this provider in the 95th percentile of 10,533 family medicine providers in California.

See all family medicine providers in California

Medicare billing

Part B allowed, 2024
$35,929
Medicare patients
93
Services billed
319

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban64$65,077
JanuviaSitagliptin Phosphate26$41,273
OzempicSemaglutide17$18,854
JanumetSitagliptin Phos/Metformin Hcl19$18,335
JardianceEmpagliflozin11$17,852
EntrestoSacubitril/Valsartan17$15,264
Atorvastatin Calcium518$7,507
Wixela InhubFluticasone Propion/Salmeterol16$4,414
Omeprazole272$4,301
Levothyroxine Sodium211$3,454
Rosuvastatin Calcium154$3,413
Lisinopril344$2,550
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen136$2,147
Metformin Hcl237$2,075
Tamsulosin Hcl155$2,000

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis, Paxlovid$55$66,44083 claims
MerckJanuvia, Janumet$58$59,60945 claims
Novo NordiskOzempic$184$18,85417 claims
Boehringer IngelheimJardiance$16$17,85211 claims
NovartisEntresto$43$15,26417 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 10,533 family medicine providers in California.

Other family medicine in Santa Ana

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →